Research and Development

 Premier Research Group has announced the appointment of Etienne Drouet to the position of executive director, Oncology Europe.In this position, …

Bill Gates has called on global leaders to invest in innovations that are accelerating progress against poverty, or risk a …

The government’s new vision for public health has come under fire from observers worried that accountability for the strategy remains …

In accordance with the provisions of the new pharmacovigilance legislation, as per Directive 2010/84/EU, EU Competent Authorities may inspect the …

Big pharma is going through the greatest ever wave of patent expiries, while small biotechs are finding it hard to …

Celgene, the biopharma firm specialising in cancer and inflammatory diseases, has elected Richard Barker to its board of directors. Dr …

Alnylam will cut 33% of its workforce this year as it looks to focus on developing its own products. The …

Quintiles invests in new biomarket firm and sets up a new office in China, plus updates from vivoPharma, CoreLab Partners …

Changes are being made in the way fees are paid for regulatory submissions and procedures in France.  Fees are no …

A European committee has recommended Novartis’ Signifor for the treatment of a rare, debilitating endocrine disorder. The European Committee for …

The European Medicines Agency has begun a review into the safety of Novartis’ multiple sclerosis drug Gilenya. This follows concerns …

AstraZeneca and Bristol-Myers Squibb must supply more data on their diabetes treatment dapagliflozin, the FDA says.Currently being developed as monotherapy, …

Novartis has begun Phase III biosimilar trials to copycat two of Amgen’s neutropenia drugs. The studies, which are being undertaken …

Clinigen Group, a global specialty pharma services and products business, has appointed Shaun Chilton as its new chief operating officer …

Takeda has announced plans to significantly reduce its global headcount over the next four years following its merger with Nycomed. …